Formulation of liposomes functionalized with Lotus lectin and effective in targeting highly proliferative cells

Liposomes, used to improve the therapeutic index of new and established drugs, have advanced with the insertion of active targeting. The lectin from Lotus tetragonolobus (LTL), which binds glycans containing alpha-1,2-linked fucose, reveals surface regionalized glycoepitopes in highly proliferative...

Full description

Saved in:
Bibliographic Details
Published inBiochimica et biophysica acta. General subjects Vol. 1861; no. 4; pp. 860 - 870
Main Authors Della Giovampaola, Cinzia, Capone, Antonietta, Ermini, Leonardo, Lupetti, Pietro, Vannuccini, Elisa, Finetti, Federica, Donnini, Sandra, Ziche, Marina, Magnani, Agnese, Leone, Gemma, Rossi, Claudio, Rosati, Floriana, Bonechi, Claudia
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.04.2017
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Liposomes, used to improve the therapeutic index of new and established drugs, have advanced with the insertion of active targeting. The lectin from Lotus tetragonolobus (LTL), which binds glycans containing alpha-1,2-linked fucose, reveals surface regionalized glycoepitopes in highly proliferative cells not detectable in normally growing cells. In contrast, other lectins localize the corresponding glycoepitopes all over the cell surface. LTL also proved able to penetrate the cells by an unconventional uptake mechanism. We used confocal laser microscopy to detect and localize LTL-positive glycoepitopes and lectin uptake in two cancer cell lines. We then constructed doxorubicin-loaded liposomes functionalized with LTL. Intracellular delivery of the drug was determined in vitro and in vivo by confocal and electron microscopy. We confirmed the specific localization of Lotus binding sites and the lectin uptake mechanism in the two cell lines and determined that LTL-functionalized liposomes loaded with doxorubicin greatly increased intracellular delivery of the drug, compared to unmodified doxorubicin-loaded liposomes. The LTL-Dox-L mechanism of entry and drug delivery was different to that of Dox-L and other liposomal preparations. LTL-Dox-L entered the cells one by one in tiny tubules that never fused with lysosomes. LTL-Dox-L injected in mice with melanoma specifically delivered loaded Dox to the cytoplasm of tumor cells. Liposome functionalization with LTL promises to broaden the therapeutic potential of liposomal doxorubicin treatment, decreasing non-specific toxicity. Doxorubicin-LTL functionalized liposomes promise to be useful in the development of new cancer chemotherapy protocols.
AbstractList Liposomes, used to improve the therapeutic index of new and established drugs, have advanced with the insertion of active targeting. The lectin from Lotus tetragonolobus (LTL), which binds glycans containing alpha-1,2-linked fucose, reveals surface regionalized glycoepitopes in highly proliferative cells not detectable in normally growing cells. In contrast, other lectins localize the corresponding glycoepitopes all over the cell surface. LTL also proved able to penetrate the cells by an unconventional uptake mechanism.BACKGROUNDLiposomes, used to improve the therapeutic index of new and established drugs, have advanced with the insertion of active targeting. The lectin from Lotus tetragonolobus (LTL), which binds glycans containing alpha-1,2-linked fucose, reveals surface regionalized glycoepitopes in highly proliferative cells not detectable in normally growing cells. In contrast, other lectins localize the corresponding glycoepitopes all over the cell surface. LTL also proved able to penetrate the cells by an unconventional uptake mechanism.We used confocal laser microscopy to detect and localize LTL-positive glycoepitopes and lectin uptake in two cancer cell lines. We then constructed doxorubicin-loaded liposomes functionalized with LTL. Intracellular delivery of the drug was determined in vitro and in vivo by confocal and electron microscopy.METHODSWe used confocal laser microscopy to detect and localize LTL-positive glycoepitopes and lectin uptake in two cancer cell lines. We then constructed doxorubicin-loaded liposomes functionalized with LTL. Intracellular delivery of the drug was determined in vitro and in vivo by confocal and electron microscopy.We confirmed the specific localization of Lotus binding sites and the lectin uptake mechanism in the two cell lines and determined that LTL-functionalized liposomes loaded with doxorubicin greatly increased intracellular delivery of the drug, compared to unmodified doxorubicin-loaded liposomes. The LTL-Dox-L mechanism of entry and drug delivery was different to that of Dox-L and other liposomal preparations. LTL-Dox-L entered the cells one by one in tiny tubules that never fused with lysosomes. LTL-Dox-L injected in mice with melanoma specifically delivered loaded Dox to the cytoplasm of tumor cells.RESULTSWe confirmed the specific localization of Lotus binding sites and the lectin uptake mechanism in the two cell lines and determined that LTL-functionalized liposomes loaded with doxorubicin greatly increased intracellular delivery of the drug, compared to unmodified doxorubicin-loaded liposomes. The LTL-Dox-L mechanism of entry and drug delivery was different to that of Dox-L and other liposomal preparations. LTL-Dox-L entered the cells one by one in tiny tubules that never fused with lysosomes. LTL-Dox-L injected in mice with melanoma specifically delivered loaded Dox to the cytoplasm of tumor cells.Liposome functionalization with LTL promises to broaden the therapeutic potential of liposomal doxorubicin treatment, decreasing non-specific toxicity.CONCLUSIONSLiposome functionalization with LTL promises to broaden the therapeutic potential of liposomal doxorubicin treatment, decreasing non-specific toxicity.Doxorubicin-LTL functionalized liposomes promise to be useful in the development of new cancer chemotherapy protocols.GENERAL SIGNIFICANCEDoxorubicin-LTL functionalized liposomes promise to be useful in the development of new cancer chemotherapy protocols.
Liposomes, used to improve the therapeutic index of new and established drugs, have advanced with the insertion of active targeting. The lectin from Lotus tetragonolobus (LTL), which binds glycans containing alpha-1,2-linked fucose, reveals surface regionalized glycoepitopes in highly proliferative cells not detectable in normally growing cells. In contrast, other lectins localize the corresponding glycoepitopes all over the cell surface. LTL also proved able to penetrate the cells by an unconventional uptake mechanism. We used confocal laser microscopy to detect and localize LTL-positive glycoepitopes and lectin uptake in two cancer cell lines. We then constructed doxorubicin-loaded liposomes functionalized with LTL. Intracellular delivery of the drug was determined in vitro and in vivo by confocal and electron microscopy. We confirmed the specific localization of Lotus binding sites and the lectin uptake mechanism in the two cell lines and determined that LTL-functionalized liposomes loaded with doxorubicin greatly increased intracellular delivery of the drug, compared to unmodified doxorubicin-loaded liposomes. The LTL-Dox-L mechanism of entry and drug delivery was different to that of Dox-L and other liposomal preparations. LTL-Dox-L entered the cells one by one in tiny tubules that never fused with lysosomes. LTL-Dox-L injected in mice with melanoma specifically delivered loaded Dox to the cytoplasm of tumor cells. Liposome functionalization with LTL promises to broaden the therapeutic potential of liposomal doxorubicin treatment, decreasing non-specific toxicity. Doxorubicin-LTL functionalized liposomes promise to be useful in the development of new cancer chemotherapy protocols.
Liposomes, used to improve the therapeutic index of new and established drugs, have advanced with the insertion of active targeting. The lectin from Lotus tetragonolobus (LTL), which binds glycans containing alpha-1,2-linked fucose, reveals surface regionalized glycoepitopes in highly proliferative cells not detectable in normally growing cells. In contrast, other lectins localize the corresponding glycoepitopes all over the cell surface. LTL also proved able to penetrate the cells by an unconventional uptake mechanism.We used confocal laser microscopy to detect and localize LTL-positive glycoepitopes and lectin uptake in two cancer cell lines. We then constructed doxorubicin-loaded liposomes functionalized with LTL. Intracellular delivery of the drug was determined in vitro and in vivo by confocal and electron microscopy.We confirmed the specific localization of Lotus binding sites and the lectin uptake mechanism in the two cell lines and determined that LTL-functionalized liposomes loaded with doxorubicin greatly increased intracellular delivery of the drug, compared to unmodified doxorubicin-loaded liposomes. The LTL-Dox-L mechanism of entry and drug delivery was different to that of Dox-L and other liposomal preparations. LTL-Dox-L entered the cells one by one in tiny tubules that never fused with lysosomes. LTL-Dox-L injected in mice with melanoma specifically delivered loaded Dox to the cytoplasm of tumor cells.Liposome functionalization with LTL promises to broaden the therapeutic potential of liposomal doxorubicin treatment, decreasing non-specific toxicity.Doxorubicin-LTL functionalized liposomes promise to be useful in the development of new cancer chemotherapy protocols.
Author Finetti, Federica
Ziche, Marina
Magnani, Agnese
Donnini, Sandra
Rossi, Claudio
Leone, Gemma
Bonechi, Claudia
Capone, Antonietta
Rosati, Floriana
Della Giovampaola, Cinzia
Ermini, Leonardo
Vannuccini, Elisa
Lupetti, Pietro
Author_xml – sequence: 1
  givenname: Cinzia
  surname: Della Giovampaola
  fullname: Della Giovampaola, Cinzia
  organization: Department of Life Sciences, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy
– sequence: 2
  givenname: Antonietta
  surname: Capone
  fullname: Capone, Antonietta
  organization: Department of Life Sciences, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy
– sequence: 3
  givenname: Leonardo
  surname: Ermini
  fullname: Ermini, Leonardo
  organization: Department of Life Sciences, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy
– sequence: 4
  givenname: Pietro
  surname: Lupetti
  fullname: Lupetti, Pietro
  organization: Department of Life Sciences, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy
– sequence: 5
  givenname: Elisa
  surname: Vannuccini
  fullname: Vannuccini, Elisa
  organization: Department of Life Sciences, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy
– sequence: 6
  givenname: Federica
  surname: Finetti
  fullname: Finetti, Federica
  organization: Department of Life Sciences, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy
– sequence: 7
  givenname: Sandra
  surname: Donnini
  fullname: Donnini, Sandra
  organization: Department of Life Sciences, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy
– sequence: 8
  givenname: Marina
  surname: Ziche
  fullname: Ziche, Marina
  organization: Department of Life Sciences, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy
– sequence: 9
  givenname: Agnese
  surname: Magnani
  fullname: Magnani, Agnese
  organization: Department of Biotechnology, Chemistry, and Pharmacy, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy
– sequence: 10
  givenname: Gemma
  surname: Leone
  fullname: Leone, Gemma
  organization: Department of Biotechnology, Chemistry, and Pharmacy, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy
– sequence: 11
  givenname: Claudio
  surname: Rossi
  fullname: Rossi, Claudio
  organization: Department of Biotechnology, Chemistry, and Pharmacy, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy
– sequence: 12
  givenname: Floriana
  surname: Rosati
  fullname: Rosati, Floriana
  organization: Department of Life Sciences, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy
– sequence: 13
  givenname: Claudia
  surname: Bonechi
  fullname: Bonechi, Claudia
  email: claudia.bonechi@unisi.it
  organization: Department of Biotechnology, Chemistry, and Pharmacy, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28095317$$D View this record in MEDLINE/PubMed
BookMark eNqFkcFu1DAQhi1URLeFN0DIRy67Hcexk3BAQhUFpJW4wNly7PGuV0682Emr8vQ43cKBQ2uNZM3M949G81-QszGOSMhbBhsGTF4dNn2vdzhuKmDNBlgJ8YKsWNtU6xZAnpEVcKjXNZPinFzkfIDyRCdekfOqhU5w1qxIvIlpmIOefBxpdDT4Y8xxwEzdPJqlqoP_jZbe-WlPt3GaMw1YGiPVo6Xo3JLcIi2FSacdls6O7v1uH-7pMcXgHSb9QBgMIb8mL50OGd88_pfk583nH9df19vvX75df9quTV2zac206NFWWnRd4yxD23e9bQXIxkjHuQFg3HWSuaq3puZgZc2gdsARZCUbyy_J-9PcssOvGfOkBp-XDfSIcc6qKrfgsgHePouyVjLRVKJpCvruEZ37Aa06Jj_odK_-3rMA9QkwKeac0P1DGKjFNnVQJ9vUYpsCVkIU2Yf_ZMZPD55MSfvwnPjjSYzlnrcek8rG42jQ-lTMUTb6pwf8AVAqtok
CitedBy_id crossref_primary_10_3390_nano11020289
crossref_primary_10_1039_C7RA12543G
crossref_primary_10_1016_j_bpc_2019_106149
crossref_primary_10_3390_cancers14040911
crossref_primary_10_1016_j_molstruc_2019_127264
crossref_primary_10_3390_ph14090835
crossref_primary_10_1039_D0BM01531H
crossref_primary_10_1016_j_mtcomm_2019_100634
crossref_primary_10_1002_adv_21965
crossref_primary_10_1016_j_bbagen_2023_130517
crossref_primary_10_1016_j_ijpharm_2024_124685
crossref_primary_10_1016_j_bpc_2019_01_002
crossref_primary_10_1016_j_yexcr_2020_112324
crossref_primary_10_1016_j_onano_2022_100080
crossref_primary_10_1016_j_jddst_2017_09_019
crossref_primary_10_1016_j_carbpol_2019_115347
crossref_primary_10_1016_j_carbpol_2024_121780
crossref_primary_10_1016_j_bpc_2024_107381
crossref_primary_10_1016_j_ntm_2024_100054
crossref_primary_10_1016_j_chembiol_2024_09_010
crossref_primary_10_1016_j_mehy_2018_05_002
crossref_primary_10_1080_00387010_2018_1556700
crossref_primary_10_1159_000513430
crossref_primary_10_1016_j_ijpharm_2021_120413
crossref_primary_10_3390_pharmaceutics13101617
crossref_primary_10_1080_00914037_2020_1848831
crossref_primary_10_1007_s00432_018_2726_1
crossref_primary_10_3390_biomedicines8120580
crossref_primary_10_2217_nnm_2019_0308
crossref_primary_10_1016_j_bpc_2017_11_003
Cites_doi 10.1038/nrd1632
10.1016/0039-9140(96)01932-7
10.3109/02652049509010292
10.4103/0973-1482.139267
10.1063/1.1678153
10.1016/S0076-6879(07)38006-3
10.1146/annurev-pathol-012414-040438
10.3389/fphar.2015.00286
10.1038/nrd2897
10.1016/j.bbamem.2008.12.019
10.1016/B978-0-12-397945-2.00014-7
10.1073/pnas.78.7.4515
10.1371/journal.pone.0041438
10.7554/eLife.00090
10.1200/JCO.2001.19.5.1444
10.1016/j.addr.2003.10.015
10.1097/CAD.0000000000000182
10.1016/j.jconrel.2010.01.036
10.1016/j.juro.2011.05.040
10.1038/nrm2216
10.1038/227680a0
10.1016/j.ijpharm.2005.04.029
10.2310/7290.2010.00054
10.1097/FPC.0b013e32833ffb56
10.1016/j.biomaterials.2009.05.031
10.1016/S0169-409X(02)00042-X
10.3389/fchem.2014.00105
10.1016/j.acthis.2010.02.004
10.1002/pmic.201300387
10.1016/0009-3084(93)90064-A
10.1016/j.carbpol.2011.12.047
10.1093/glycob/cwp065
10.3109/10611860108997933
10.1016/j.addr.2016.04.014
10.1016/j.biotechadv.2013.01.005
10.1016/j.tice.2014.10.007
ContentType Journal Article
Copyright 2017 Elsevier B.V.
Copyright © 2017 Elsevier B.V. All rights reserved.
Copyright_xml – notice: 2017 Elsevier B.V.
– notice: Copyright © 2017 Elsevier B.V. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7S9
L.6
DOI 10.1016/j.bbagen.2017.01.015
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE
AGRICOLA
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
Biology
EISSN 1872-8006
EndPage 870
ExternalDocumentID 28095317
10_1016_j_bbagen_2017_01_015
S0304416517300156
Genre Journal Article
GroupedDBID ---
--K
--M
.~1
0R~
1B1
1RT
1~.
1~5
23N
3O-
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
71M
8P~
9JM
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AAXUO
ABEFU
ABFNM
ABGSF
ABMAC
ABUDA
ABXDB
ABYKQ
ACDAQ
ACIUM
ACRLP
ADBBV
ADEZE
ADMUD
ADUVX
AEBSH
AEHWI
AEKER
AFKWA
AFTJW
AFXIZ
AGHFR
AGRDE
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
CS3
DOVZS
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HLW
HVGLF
HZ~
IHE
J1W
KOM
LX3
M41
MO0
N9A
O-L
O9-
OAUVE
OHT
OZT
P-8
P-9
PC.
Q38
R2-
ROL
RPZ
SBG
SCC
SDF
SDG
SDP
SES
SEW
SPCBC
SSU
SSZ
T5K
UQL
WH7
WUQ
XJT
XPP
~G-
AAHBH
AATTM
AAXKI
AAYWO
AAYXX
ABWVN
ACRPL
ACVFH
ADCNI
ADNMO
AEIPS
AEUPX
AFJKZ
AFPUW
AGCQF
AGQPQ
AGRNS
AIGII
AIIUN
AKBMS
AKRWK
AKYEP
ANKPU
APXCP
BNPGV
CITATION
SSH
CGR
CUY
CVF
ECM
EFKBS
EIF
NPM
7X8
7S9
L.6
ID FETCH-LOGICAL-c441t-1a5bed2a5997fd1edb9bd85067c6f33c0013f961f2bdc430d64104f03e06267d3
IEDL.DBID .~1
ISSN 0304-4165
IngestDate Fri Jul 11 10:53:15 EDT 2025
Fri Jul 11 13:22:53 EDT 2025
Mon Jul 21 05:42:28 EDT 2025
Tue Jul 01 00:22:08 EDT 2025
Thu Apr 24 23:00:34 EDT 2025
Fri Feb 23 02:32:42 EST 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords DOPE
LTL
LTL-Dex-L
LTL-Dox-L
Drug delivery
Targeted liposomes
Dox
L
Lotus lectin
Doxorubicin
NMR
LTL-L
Dex
Dex-L
DOPC
Dox-L
Language English
License Copyright © 2017 Elsevier B.V. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c441t-1a5bed2a5997fd1edb9bd85067c6f33c0013f961f2bdc430d64104f03e06267d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink http://hdl.handle.net/11365/1004600
PMID 28095317
PQID 1861572577
PQPubID 23479
PageCount 11
ParticipantIDs proquest_miscellaneous_2000367038
proquest_miscellaneous_1861572577
pubmed_primary_28095317
crossref_primary_10_1016_j_bbagen_2017_01_015
crossref_citationtrail_10_1016_j_bbagen_2017_01_015
elsevier_sciencedirect_doi_10_1016_j_bbagen_2017_01_015
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate April 2017
2017-04-00
2017-Apr
20170401
PublicationDateYYYYMMDD 2017-04-01
PublicationDate_xml – month: 04
  year: 2017
  text: April 2017
PublicationDecade 2010
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle Biochimica et biophysica acta. General subjects
PublicationTitleAlternate Biochim Biophys Acta Gen Subj
PublicationYear 2017
Publisher Elsevier B.V
Publisher_xml – name: Elsevier B.V
References Torchilin (bb0005) 2005; 4
Batist, Ramakrishnan, Rao, Chandrasekharan, Gutheil, Guthrie, Shah, Khojasteh, Nair, Hoelzer, Tkaczuk, Park, Lee (bb0020) 2001; 19
Rivankar (bb0010) 2014; 10
Leone, Consumi, Lamponi, Magnani (bb0090) 2012; 88
Christiansen, Chik, Ling, Anugrahm, Abrahams, Packer (bb0040) 2014; 14
Langley (bb0095) 1992
Powlesland, Hitchen, Parry, Graham, Barrio, Elola, Mordoh, Dell, Drickamer, Taylor (bb0045) 2009; 19
Sahay, Alakhova, Kabanov (bb0170) 2010; 145
Koppel (bb0100) 1972; 57
Ghazarian, Idoni, Oppenheimer (bb0035) 2011; 113
Laemmli (bb0085) 1970; 27
Aldi, Capone, Della Giovampaola, Ermini, Pianigiani, Mariotti, Rosati (bb0070) 2015; 47
Bonechi, Ristori, Martini, Martini, Rossi (bb0135) 2009; 1788
Sercombe, Veerati, Moheimani, Wu, Sood, Hua (bb0160) 2015; 6
Stowell, Ju, Cummings (bb0050) 2011; 10
Bonechi, Martini, Ciani, Lamponi, Setzer, Rebmann, Rossi, Ristori (bb0075) 2012; 7
Tomoko, Fumiyoshi (bb0130) 2005; 298
Cevc (bb0120) 1993; 64
Rajendran, Knolker, Simons (bb0015) 2010; 9
Neutsch, Plattner, Polster-Wildhofen, Zidar, Chott, Borchard, Zechner, Gabor, Wirth (bb0180) 2011; 186
Tahover, Patil, Gabizon (bb0025) 2015; 26
Sastry, Lingeswara Rao (bb0105) 1996; 43
Gabor, Bogner, Weissenboech, Virth (bb0060) 2004; 56
Chun, Lee, Kim, Hong, Kim, Yang, Song (bb0140) 2009; 30
Sutherland, Delia, Schneider, Newman, Kemshead, Greaves (bb0155) 1981; 78
Conniot, Silva, Fernandez, Silva, Gaspar, Brocchini, Florindo, Barata (bb0030) 2014; 2
Levitt (bb0145) 2001
Lu, Low (bb0150) 2002; 54
Roney, Xu, Xie, Yuan, Wierwille, Chen, Griffiths, Summers (bb0055) 2011; 10
Gajbhiye, Gong (bb0065) 2013; 31
Kirchhausen, Macia, Pelish (bb0115) 2008; 438
Kulkarni, Betageri, Singh (bb0125) 1995; 12
Satyajit, Pagano (bb0185) 2007; 8
Hunter (bb0080) 1988
Beloqui, des Rieux, Préat (bb0165) 2016; 106
Thorn, Oshiro, Marsh, Hernandez-Boussard, McLeod, Klein, Altman (bb0190) 2011; 21
Brück, Abu-Dahab, Borchard, Schäfer, Lehr (bb0175) 2001; 9
Rogowski, Scholz, Geimer (bb0110) 2013; 524
Denard, Lee, Ye (bb0195) 2012; 1
Hunter (10.1016/j.bbagen.2017.01.015_bb0080) 1988
Bonechi (10.1016/j.bbagen.2017.01.015_bb0075) 2012; 7
Roney (10.1016/j.bbagen.2017.01.015_bb0055) 2011; 10
Gajbhiye (10.1016/j.bbagen.2017.01.015_bb0065) 2013; 31
Langley (10.1016/j.bbagen.2017.01.015_bb0095) 1992
Powlesland (10.1016/j.bbagen.2017.01.015_bb0045) 2009; 19
Leone (10.1016/j.bbagen.2017.01.015_bb0090) 2012; 88
Tomoko (10.1016/j.bbagen.2017.01.015_bb0130) 2005; 298
Sahay (10.1016/j.bbagen.2017.01.015_bb0170) 2010; 145
Sastry (10.1016/j.bbagen.2017.01.015_bb0105) 1996; 43
Kulkarni (10.1016/j.bbagen.2017.01.015_bb0125) 1995; 12
Satyajit (10.1016/j.bbagen.2017.01.015_bb0185) 2007; 8
Chun (10.1016/j.bbagen.2017.01.015_bb0140) 2009; 30
Neutsch (10.1016/j.bbagen.2017.01.015_bb0180) 2011; 186
Rajendran (10.1016/j.bbagen.2017.01.015_bb0015) 2010; 9
Tahover (10.1016/j.bbagen.2017.01.015_bb0025) 2015; 26
Levitt (10.1016/j.bbagen.2017.01.015_bb0145) 2001
Christiansen (10.1016/j.bbagen.2017.01.015_bb0040) 2014; 14
Denard (10.1016/j.bbagen.2017.01.015_bb0195) 2012; 1
Bonechi (10.1016/j.bbagen.2017.01.015_bb0135) 2009; 1788
Koppel (10.1016/j.bbagen.2017.01.015_bb0100) 1972; 57
Rivankar (10.1016/j.bbagen.2017.01.015_bb0010) 2014; 10
Torchilin (10.1016/j.bbagen.2017.01.015_bb0005) 2005; 4
Rogowski (10.1016/j.bbagen.2017.01.015_bb0110) 2013; 524
Brück (10.1016/j.bbagen.2017.01.015_bb0175) 2001; 9
Sercombe (10.1016/j.bbagen.2017.01.015_bb0160) 2015; 6
Ghazarian (10.1016/j.bbagen.2017.01.015_bb0035) 2011; 113
Gabor (10.1016/j.bbagen.2017.01.015_bb0060) 2004; 56
Cevc (10.1016/j.bbagen.2017.01.015_bb0120) 1993; 64
Stowell (10.1016/j.bbagen.2017.01.015_bb0050) 2011; 10
Batist (10.1016/j.bbagen.2017.01.015_bb0020) 2001; 19
Kirchhausen (10.1016/j.bbagen.2017.01.015_bb0115) 2008; 438
Lu (10.1016/j.bbagen.2017.01.015_bb0150) 2002; 54
Sutherland (10.1016/j.bbagen.2017.01.015_bb0155) 1981; 78
Aldi (10.1016/j.bbagen.2017.01.015_bb0070) 2015; 47
Conniot (10.1016/j.bbagen.2017.01.015_bb0030) 2014; 2
Beloqui (10.1016/j.bbagen.2017.01.015_bb0165) 2016; 106
Thorn (10.1016/j.bbagen.2017.01.015_bb0190) 2011; 21
Laemmli (10.1016/j.bbagen.2017.01.015_bb0085) 1970; 27
References_xml – volume: 31
  start-page: 552
  year: 2013
  end-page: 562
  ident: bb0065
  article-title: Lectin functionalized nanocarriers for gene delivery
  publication-title: Biotechnol. Adv.
– volume: 57
  start-page: 4814
  year: 1972
  end-page: 4820
  ident: bb0100
  article-title: Analysis of macromolecular polydispersity in intensity correlation spectroscopy: the method of cumulants
  publication-title: J. Chem. Phys.
– volume: 113
  start-page: 236
  year: 2011
  end-page: 247
  ident: bb0035
  article-title: A glycobiology review: carbohydrates, lectins, and implications in cancer therapeutics
  publication-title: Acta Histochem.
– volume: 145
  start-page: 182
  year: 2010
  end-page: 195
  ident: bb0170
  article-title: Endocytosis of nanomedicines
  publication-title: J. Control. Release
– volume: 43
  start-page: 1827
  year: 1996
  end-page: 1835
  ident: bb0105
  article-title: Determination of doxorubicin hydrochloride by visible spectrophotometry
  publication-title: Talanta
– volume: 10
  start-page: 473
  year: 2011
  end-page: 510
  ident: bb0050
  article-title: Protein glycosylation in cancer
  publication-title: Annu. Rev. Pathol.
– volume: 8
  start-page: 603
  year: 2007
  end-page: 612
  ident: bb0185
  article-title: Pathways of clathrin-independent endocytosis
  publication-title: Nat. Rev. Mol. Cell Biol.
– volume: 47
  start-page: 33
  year: 2015
  end-page: 38
  ident: bb0070
  article-title: Identification of a novel, alpha2-fucosylation-dependent uptake system in highly proliferative cells
  publication-title: Tissue Cell
– volume: 9
  start-page: 241
  year: 2001
  end-page: 251
  ident: bb0175
  article-title: Lectin-functionalized liposomes for pulmonary drug delivery: interaction with human alveolar epithelial cells
  publication-title: J. Drug Target.
– volume: 106
  start-page: 242
  year: 2016
  end-page: 255
  ident: bb0165
  article-title: Mechanisms of transport of polymeric and lipidic nanoparticles across the intestinal barrier
  publication-title: Adv. Drug Deliv. Rev.
– volume: 19
  start-page: 899
  year: 2009
  end-page: 909
  ident: bb0045
  article-title: Targeted glycoproteomic identification of cancer cell glycosylation
  publication-title: Glycobiology
– volume: 4
  start-page: 145
  year: 2005
  end-page: 160
  ident: bb0005
  article-title: Recent advances with liposomes as pharmaceutical carriers
  publication-title: Nat. Rev. Drug Discov.
– volume: 298
  start-page: 198
  year: 2005
  end-page: 205
  ident: bb0130
  article-title: Encapsulation efficiency of water-soluble and insoluble drugs in liposomes prepared by the microencapsulation vesicle method
  publication-title: Int. J. Pharm.
– year: 1988
  ident: bb0080
  article-title: Zeta Potential in Colloid Science: Principles And Application
– volume: 56
  start-page: 459
  year: 2004
  end-page: 480
  ident: bb0060
  article-title: The lectin-cell interaction and its implications to intestinal lectin-mediated drug delivery
  publication-title: Adv. Drug Deliv. Rev.
– volume: 1788
  start-page: 708
  year: 2009
  end-page: 716
  ident: bb0135
  article-title: Study of bradykinin conformation in the presence of model membrane by Nuclear Magnetic Resonance and molecular modeling
  publication-title: Biochim. Biophys. Acta
– volume: 9
  start-page: 29
  year: 2010
  end-page: 42
  ident: bb0015
  article-title: Subcellular targeting strategies for drug design and delivery
  publication-title: Nat. Rev. Drug Discov.
– volume: 524
  start-page: 243
  year: 2013
  end-page: 263
  ident: bb0110
  article-title: Electron microscopy of flagella, primary cilia, and intraflagellar transport in flat-embedded cells
  publication-title: Methods Enzymol.
– start-page: 151
  year: 1992
  end-page: 160
  ident: bb0095
  article-title: Developments in electrophoretic laser light scattering and some of biochemical applications
  publication-title: Laser Light Scattering in Biochemistry
– volume: 78
  start-page: 4515
  year: 1981
  end-page: 4519
  ident: bb0155
  article-title: Ubiquitous cell-surface glycoprotein on tumor cells is proliferation-associated receptor for transferring
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– volume: 14
  start-page: 525
  year: 2014
  end-page: 546
  ident: bb0040
  article-title: Cell surface protein glycosylation in cancer
  publication-title: Proteomics
– volume: 21
  start-page: 440
  year: 2011
  end-page: 446
  ident: bb0190
  article-title: Doxorubicin pathways: pharmacodynamics and adverse effects
  publication-title: Pharmacogenet. Genomics
– volume: 54
  start-page: 675
  year: 2002
  end-page: 693
  ident: bb0150
  article-title: Folate-mediated delivery of macromolecular anticancer therapeutic agents
  publication-title: Adv. Drug Deliv. Rev.
– volume: 6
  start-page: 286
  year: 2015
  end-page: 289
  ident: bb0160
  article-title: Advances and challenges of liposome assisted drug delivery
  publication-title: Front. Pharmacol.
– volume: 88
  start-page: 799
  year: 2012
  end-page: 808
  ident: bb0090
  article-title: New hyaluroran derivative with prolonged half-life for ophthalmological formulation
  publication-title: Carbohydr. Polym.
– volume: 438
  start-page: 77
  year: 2008
  end-page: 93
  ident: bb0115
  article-title: Use of dynasore, the small molecule inhibitor of dynamin, in the regulation of endocytosis
  publication-title: Methods Enzymol.
– year: 2001
  ident: bb0145
  article-title: Basic of nuclear magnetic resonance
– volume: 64
  start-page: 163
  year: 1993
  end-page: 186
  ident: bb0120
  article-title: Electrostatic characterization of liposomes
  publication-title: Chem. Phys. Lipids
– volume: 30
  start-page: 4752
  year: 2009
  end-page: 4762
  ident: bb0140
  article-title: Doxorubicin-polyphosphazene conjugate hydrogels for locally controlled delivery of cancer therapeutics
  publication-title: Biomaterials
– volume: 26
  start-page: 241
  year: 2015
  end-page: 258
  ident: bb0025
  article-title: Emerging delivery systems to reduce Doxorubicin cardiotoxicity and improve therapeutic index: focus on liposomes
  publication-title: Anticancer Drugs
– volume: 27
  start-page: 680
  year: 1970
  end-page: 685
  ident: bb0085
  article-title: Cleavage of structural proteins during the assembly of the head of the bacteriophage T4
  publication-title: Nature
– volume: 7
  start-page: e41438
  year: 2012
  ident: bb0075
  article-title: Using liposomes as carriers for polyphenolic compounds: the case of trans-resveratrol
  publication-title: PLoS One
– volume: 12
  start-page: 229
  year: 1995
  end-page: 246
  ident: bb0125
  article-title: Factors affecting microencapsulation of drugs in liposomes
  publication-title: J. Microencapsul.
– volume: 10
  start-page: 853
  year: 2014
  end-page: 858
  ident: bb0010
  article-title: An overview of Doxorubicin formulation in cancer therapy
  publication-title: J. Cancer Res. Ther.
– volume: 19
  start-page: 1444
  year: 2001
  end-page: 1454
  ident: bb0020
  article-title: Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated Doxorubicin and cyclo phosphamide compared with conventional Doxorubicin and cyclo phosphamide in a randomized multicenter trial of metastatic breast cancer
  publication-title: J. Clin. Oncol.
– volume: 186
  start-page: 1481
  year: 2011
  end-page: 1488
  ident: bb0180
  article-title: Lectin mediated biorecognition as a novel strategy for targeted delivery to bladder cancer
  publication-title: J. Urol.
– volume: 2
  start-page: 105
  year: 2014
  end-page: 132
  ident: bb0030
  article-title: Cancer immunotherapy: nanodelivery approaches for immune cell targeting and tracking
  publication-title: Front. Chem.
– volume: 1
  start-page: e00090
  year: 2012
  ident: bb0195
  article-title: Doxorubicin blocks proliferation of cancer cells through proteolytic activation of CREB3L1
  publication-title: eLife Sci.
– volume: 10
  start-page: 305
  year: 2011
  end-page: 316
  ident: bb0055
  article-title: Rh-I-UEA-1 polymerized liposomes target and image adenomatous polyps in the APC(Min/+) mouse using optical colonography
  publication-title: Mol. Imaging
– volume: 4
  start-page: 145
  year: 2005
  ident: 10.1016/j.bbagen.2017.01.015_bb0005
  article-title: Recent advances with liposomes as pharmaceutical carriers
  publication-title: Nat. Rev. Drug Discov.
  doi: 10.1038/nrd1632
– volume: 43
  start-page: 1827
  year: 1996
  ident: 10.1016/j.bbagen.2017.01.015_bb0105
  article-title: Determination of doxorubicin hydrochloride by visible spectrophotometry
  publication-title: Talanta
  doi: 10.1016/0039-9140(96)01932-7
– volume: 12
  start-page: 229
  year: 1995
  ident: 10.1016/j.bbagen.2017.01.015_bb0125
  article-title: Factors affecting microencapsulation of drugs in liposomes
  publication-title: J. Microencapsul.
  doi: 10.3109/02652049509010292
– volume: 10
  start-page: 853
  year: 2014
  ident: 10.1016/j.bbagen.2017.01.015_bb0010
  article-title: An overview of Doxorubicin formulation in cancer therapy
  publication-title: J. Cancer Res. Ther.
  doi: 10.4103/0973-1482.139267
– volume: 57
  start-page: 4814
  year: 1972
  ident: 10.1016/j.bbagen.2017.01.015_bb0100
  article-title: Analysis of macromolecular polydispersity in intensity correlation spectroscopy: the method of cumulants
  publication-title: J. Chem. Phys.
  doi: 10.1063/1.1678153
– volume: 438
  start-page: 77
  year: 2008
  ident: 10.1016/j.bbagen.2017.01.015_bb0115
  article-title: Use of dynasore, the small molecule inhibitor of dynamin, in the regulation of endocytosis
  publication-title: Methods Enzymol.
  doi: 10.1016/S0076-6879(07)38006-3
– volume: 10
  start-page: 473
  year: 2011
  ident: 10.1016/j.bbagen.2017.01.015_bb0050
  article-title: Protein glycosylation in cancer
  publication-title: Annu. Rev. Pathol.
  doi: 10.1146/annurev-pathol-012414-040438
– volume: 6
  start-page: 286
  year: 2015
  ident: 10.1016/j.bbagen.2017.01.015_bb0160
  article-title: Advances and challenges of liposome assisted drug delivery
  publication-title: Front. Pharmacol.
  doi: 10.3389/fphar.2015.00286
– volume: 9
  start-page: 29
  year: 2010
  ident: 10.1016/j.bbagen.2017.01.015_bb0015
  article-title: Subcellular targeting strategies for drug design and delivery
  publication-title: Nat. Rev. Drug Discov.
  doi: 10.1038/nrd2897
– year: 2001
  ident: 10.1016/j.bbagen.2017.01.015_bb0145
– volume: 1788
  start-page: 708
  year: 2009
  ident: 10.1016/j.bbagen.2017.01.015_bb0135
  article-title: Study of bradykinin conformation in the presence of model membrane by Nuclear Magnetic Resonance and molecular modeling
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/j.bbamem.2008.12.019
– volume: 524
  start-page: 243
  year: 2013
  ident: 10.1016/j.bbagen.2017.01.015_bb0110
  article-title: Electron microscopy of flagella, primary cilia, and intraflagellar transport in flat-embedded cells
  publication-title: Methods Enzymol.
  doi: 10.1016/B978-0-12-397945-2.00014-7
– volume: 78
  start-page: 4515
  year: 1981
  ident: 10.1016/j.bbagen.2017.01.015_bb0155
  article-title: Ubiquitous cell-surface glycoprotein on tumor cells is proliferation-associated receptor for transferring
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.78.7.4515
– volume: 7
  start-page: e41438
  year: 2012
  ident: 10.1016/j.bbagen.2017.01.015_bb0075
  article-title: Using liposomes as carriers for polyphenolic compounds: the case of trans-resveratrol
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0041438
– volume: 1
  start-page: e00090
  year: 2012
  ident: 10.1016/j.bbagen.2017.01.015_bb0195
  article-title: Doxorubicin blocks proliferation of cancer cells through proteolytic activation of CREB3L1
  publication-title: eLife Sci.
  doi: 10.7554/eLife.00090
– volume: 19
  start-page: 1444
  year: 2001
  ident: 10.1016/j.bbagen.2017.01.015_bb0020
  article-title: Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated Doxorubicin and cyclo phosphamide compared with conventional Doxorubicin and cyclo phosphamide in a randomized multicenter trial of metastatic breast cancer
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2001.19.5.1444
– year: 1988
  ident: 10.1016/j.bbagen.2017.01.015_bb0080
– volume: 56
  start-page: 459
  year: 2004
  ident: 10.1016/j.bbagen.2017.01.015_bb0060
  article-title: The lectin-cell interaction and its implications to intestinal lectin-mediated drug delivery
  publication-title: Adv. Drug Deliv. Rev.
  doi: 10.1016/j.addr.2003.10.015
– volume: 26
  start-page: 241
  year: 2015
  ident: 10.1016/j.bbagen.2017.01.015_bb0025
  article-title: Emerging delivery systems to reduce Doxorubicin cardiotoxicity and improve therapeutic index: focus on liposomes
  publication-title: Anticancer Drugs
  doi: 10.1097/CAD.0000000000000182
– start-page: 151
  year: 1992
  ident: 10.1016/j.bbagen.2017.01.015_bb0095
  article-title: Developments in electrophoretic laser light scattering and some of biochemical applications
– volume: 145
  start-page: 182
  year: 2010
  ident: 10.1016/j.bbagen.2017.01.015_bb0170
  article-title: Endocytosis of nanomedicines
  publication-title: J. Control. Release
  doi: 10.1016/j.jconrel.2010.01.036
– volume: 186
  start-page: 1481
  year: 2011
  ident: 10.1016/j.bbagen.2017.01.015_bb0180
  article-title: Lectin mediated biorecognition as a novel strategy for targeted delivery to bladder cancer
  publication-title: J. Urol.
  doi: 10.1016/j.juro.2011.05.040
– volume: 8
  start-page: 603
  year: 2007
  ident: 10.1016/j.bbagen.2017.01.015_bb0185
  article-title: Pathways of clathrin-independent endocytosis
  publication-title: Nat. Rev. Mol. Cell Biol.
  doi: 10.1038/nrm2216
– volume: 27
  start-page: 680
  year: 1970
  ident: 10.1016/j.bbagen.2017.01.015_bb0085
  article-title: Cleavage of structural proteins during the assembly of the head of the bacteriophage T4
  publication-title: Nature
  doi: 10.1038/227680a0
– volume: 298
  start-page: 198
  year: 2005
  ident: 10.1016/j.bbagen.2017.01.015_bb0130
  article-title: Encapsulation efficiency of water-soluble and insoluble drugs in liposomes prepared by the microencapsulation vesicle method
  publication-title: Int. J. Pharm.
  doi: 10.1016/j.ijpharm.2005.04.029
– volume: 10
  start-page: 305
  year: 2011
  ident: 10.1016/j.bbagen.2017.01.015_bb0055
  article-title: Rh-I-UEA-1 polymerized liposomes target and image adenomatous polyps in the APC(Min/+) mouse using optical colonography
  publication-title: Mol. Imaging
  doi: 10.2310/7290.2010.00054
– volume: 21
  start-page: 440
  year: 2011
  ident: 10.1016/j.bbagen.2017.01.015_bb0190
  article-title: Doxorubicin pathways: pharmacodynamics and adverse effects
  publication-title: Pharmacogenet. Genomics
  doi: 10.1097/FPC.0b013e32833ffb56
– volume: 30
  start-page: 4752
  year: 2009
  ident: 10.1016/j.bbagen.2017.01.015_bb0140
  article-title: Doxorubicin-polyphosphazene conjugate hydrogels for locally controlled delivery of cancer therapeutics
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2009.05.031
– volume: 54
  start-page: 675
  year: 2002
  ident: 10.1016/j.bbagen.2017.01.015_bb0150
  article-title: Folate-mediated delivery of macromolecular anticancer therapeutic agents
  publication-title: Adv. Drug Deliv. Rev.
  doi: 10.1016/S0169-409X(02)00042-X
– volume: 2
  start-page: 105
  year: 2014
  ident: 10.1016/j.bbagen.2017.01.015_bb0030
  article-title: Cancer immunotherapy: nanodelivery approaches for immune cell targeting and tracking
  publication-title: Front. Chem.
  doi: 10.3389/fchem.2014.00105
– volume: 113
  start-page: 236
  year: 2011
  ident: 10.1016/j.bbagen.2017.01.015_bb0035
  article-title: A glycobiology review: carbohydrates, lectins, and implications in cancer therapeutics
  publication-title: Acta Histochem.
  doi: 10.1016/j.acthis.2010.02.004
– volume: 14
  start-page: 525
  year: 2014
  ident: 10.1016/j.bbagen.2017.01.015_bb0040
  article-title: Cell surface protein glycosylation in cancer
  publication-title: Proteomics
  doi: 10.1002/pmic.201300387
– volume: 64
  start-page: 163
  year: 1993
  ident: 10.1016/j.bbagen.2017.01.015_bb0120
  article-title: Electrostatic characterization of liposomes
  publication-title: Chem. Phys. Lipids
  doi: 10.1016/0009-3084(93)90064-A
– volume: 88
  start-page: 799
  year: 2012
  ident: 10.1016/j.bbagen.2017.01.015_bb0090
  article-title: New hyaluroran derivative with prolonged half-life for ophthalmological formulation
  publication-title: Carbohydr. Polym.
  doi: 10.1016/j.carbpol.2011.12.047
– volume: 19
  start-page: 899
  year: 2009
  ident: 10.1016/j.bbagen.2017.01.015_bb0045
  article-title: Targeted glycoproteomic identification of cancer cell glycosylation
  publication-title: Glycobiology
  doi: 10.1093/glycob/cwp065
– volume: 9
  start-page: 241
  year: 2001
  ident: 10.1016/j.bbagen.2017.01.015_bb0175
  article-title: Lectin-functionalized liposomes for pulmonary drug delivery: interaction with human alveolar epithelial cells
  publication-title: J. Drug Target.
  doi: 10.3109/10611860108997933
– volume: 106
  start-page: 242
  year: 2016
  ident: 10.1016/j.bbagen.2017.01.015_bb0165
  article-title: Mechanisms of transport of polymeric and lipidic nanoparticles across the intestinal barrier
  publication-title: Adv. Drug Deliv. Rev.
  doi: 10.1016/j.addr.2016.04.014
– volume: 31
  start-page: 552
  year: 2013
  ident: 10.1016/j.bbagen.2017.01.015_bb0065
  article-title: Lectin functionalized nanocarriers for gene delivery
  publication-title: Biotechnol. Adv.
  doi: 10.1016/j.biotechadv.2013.01.005
– volume: 47
  start-page: 33
  year: 2015
  ident: 10.1016/j.bbagen.2017.01.015_bb0070
  article-title: Identification of a novel, alpha2-fucosylation-dependent uptake system in highly proliferative cells
  publication-title: Tissue Cell
  doi: 10.1016/j.tice.2014.10.007
SSID ssj0000595
Score 2.3613305
Snippet Liposomes, used to improve the therapeutic index of new and established drugs, have advanced with the insertion of active targeting. The lectin from Lotus...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 860
SubjectTerms Animals
Binding Sites
Cell Line, Tumor
Cell Proliferation - drug effects
Chemistry, Pharmaceutical - methods
confocal laser scanning microscopy
Cytoplasm - drug effects
Doxorubicin
Doxorubicin - administration & dosage
Doxorubicin - chemistry
Drug delivery
Drug Delivery Systems - methods
drug therapy
Epitopes - administration & dosage
Epitopes - chemistry
Fabaceae - metabolism
fucose
Humans
lectins
Lectins - administration & dosage
Lectins - chemistry
Liposomes - administration & dosage
Liposomes - chemistry
Lotus lectin
Lotus tetragonolobus
lysosomes
Lysosomes - drug effects
melanoma
Melanoma, Experimental - drug therapy
Mice
NMR
polysaccharides
Targeted liposomes
Title Formulation of liposomes functionalized with Lotus lectin and effective in targeting highly proliferative cells
URI https://dx.doi.org/10.1016/j.bbagen.2017.01.015
https://www.ncbi.nlm.nih.gov/pubmed/28095317
https://www.proquest.com/docview/1861572577
https://www.proquest.com/docview/2000367038
Volume 1861
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NS-wwEB9Ekfcu4sd7un4RwWveNv3YbI-yuKyfFxW8haRJobK2i9096MG_3ZmmVQRFeNBLQwJhJpn5ZTL5DcBxbIRJRSo5-uKAx8PA8dQYx10ausgE2oomm_DqejC5i8_vk_slGHVvYSitsrX93qY31rpt6bfS7M-Kon9Dl3oIJxJBlOt4DKEX7LGkVf7v9SPNA-FD4m8SYk69u-dzTY6XMbhpiQVVyIa8k4rjfu2evoOfjRsar8Naix_ZiZ_iBiy5chNWfUXJ5034NeoKuG1BNUY82lbnYlXOpsWsqqtHVzNyZj4GWLw4yygWyy6r-aJmFMQvSqZLy3ymBxpDhg0-YRzdHCN-4-kzm1G1n9x53nBG4f_6D9yNT29HE97WV-AZCm7OhU6Ms6FO0lTmVjhrUmOJwU5mgzyKMoKHeToQeWhshqq0gxgPb3kQuQCPQdJGf2G5rEq3AyzQhja31lmCPQTqWNskykTsEI7KMO5B1IlVZS35ONXAmKouy-xBeWUoUoYKBH5JD_j7qJkn3_ihv-w0pj4tIoX-4YeRR52CFWqJpKZLVy1qJYaI-SQaNvl9n7Ch9UHbOezBtl8d7_MNh8ToJ-Tuf89tD37Tn08X2ofl-dPCHSASmpvDZqkfwsrJ2cXk-g3-Fghm
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fa9swED7alNK9jK1du-ynCnsVsWwrih9LWEjXNC9roW9CsmTwSO1QJw_tX987y-4orBQGfpJPIO6ku0_S6TuAH6kVNhOZ4hiLI55OIs8zaz33WewTGxkn2mzCy-V4fp3-upE3OzDt38JQWmXn-4NPb7111zLqtDlal-XoN13qIZyQgijXcRuyC3vETiUHsHd2fjFf_nXIsi2-QvKcOvQv6No0L2tx3RIRqlAtfyfVx_13hHoJgbaRaPYO3nYQkp2FUb6HHV8dwn4oKnl_CAfTvobbEdQzhKRdgS5WF2xVruumvvUNo3gWjgHLB-8YHceyRb3ZNozO8cuKmcqxkOyB_pBhQ8gZx0jHiOJ4dc_WVPCn8IE6nNENQPMBrmc_r6Zz3pVY4DnqbsOFkda72MgsU4UT3tnMOiKxU_m4SJKcEGKRjUURW5ejNd04xf1bESU-wp2QcskxDKq68h-BRcbS-jYmlygh0MzGySQXqUdEquJ0CEmvVp13_ONUBmOl-0SzPzoYQ5MxdCTwk0PgT73WgX_jFXnVW0w_m0caQ8QrPU97A2u0EmnNVL7eNlpMEPYp9G3qZZm4ZfZB9zkZwkmYHU_jjSdE6ifUp_8e23c4mF9dLvTifHnxGd7Qn5A99AUGm7ut_4rAaGO_dRP_EQLCCxc
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Formulation+of+liposomes+functionalized+with+Lotus+lectin+and+effective+in+targeting+highly+proliferative+cells&rft.jtitle=Biochimica+et+biophysica+acta.+General+subjects&rft.au=Della+Giovampaola%2C+Cinzia&rft.au=Capone%2C+Antonietta&rft.au=Ermini%2C+Leonardo&rft.au=Lupetti%2C+Pietro&rft.date=2017-04-01&rft.issn=0304-4165&rft.volume=1861&rft.issue=4&rft.spage=860&rft_id=info:doi/10.1016%2Fj.bbagen.2017.01.015&rft_id=info%3Apmid%2F28095317&rft.externalDocID=28095317
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0304-4165&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0304-4165&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0304-4165&client=summon